CEOs 40 and Under
CEOs 40 and Under
Kevin A. Plank
Jon E. Kirchner
George G. Mueller
Jeffrey T. Housenbold
Barry Buchholtz
Richard R. Woolcott
Julie Smolyansky
James Fogarty
Jon S. Brumley
Nicholas J. DeIuliis
Ezra Uzi Yemin
Trevor Turbidy
Brett A. Roberts
David T. Blair
Todd S. Farha
David S. Kalt
J. Brandon Black
Kirk E Sanford.
J. Mariner Kemper
Mark F. Bradley
Robert R. Hill
Scot T. Wetzel
Greg Steffens
Alexis Borisy
Charles Randal Mills
Michael D. Becker
Paul L. Berns
Wayne M. Bos
Richard Chin
Mitchell H. Gold
Michael S. Weiss
Rajat Rai
W. Gray Hudkins
Joseph M. DeVivo
Michael R. Minogue
Timothy C. Choate
Peter Kosann
Vincent L. Sadusky
Michael Rapino
I. Joseph Massoud
J. Boyd Douglas
Russell C. Horowitz
Thomas L. Monahan
Frank J. Williams
Keith A. Meister
Jeffrey M. Stibel
Jeffrey Citron
David A. Steinberg
Jasper Knabb
Philip N. Kaplan
Edward B. Meyercord
Dara Khosrowshahi
Jeffrey D. Thomas
Zev Weiss
Ian Morris
Christopher A. Milner
Scott Rechler
Gordon F. DuGan
Jonathan Z. Cohen
Mark Shapiro
Robert A. Katz
Brian M. Sondey
Matthew McCauley
Eric J. Kuhn
Jonathan C. Coon
Michael J. Soenen
Matthew C. Diamond
Kenneth McBride
William P. Angrick
Frank F. Khulusi
Mark C. Vadon
Robert A. Frist
D. L. Becker
Jeffrey M. Jagid
John S. Stroup
Stephen E. Pomeroy
Peter J. Ungaro
David C.Habiger
Michael G. Rubin
Colin Angle
Neil M. Ashe
Norwood H. Davis
Ralph Bartel
Kevin M. Cameron
Dustin M. Shindo
Patrick W. Smith
Drew Fromkin
Charles M. Swoboda
Joshua G. James
R. Jordan Greenhall
Jason Hart
Michael L. Chasen
Jim McIntire
Stephen G. Waldis
Louis Hernandez
Benjamin A. Horowitz
Joe Ueberroth
Todd M. Hornbeck
Paul L. Berns, 39
CEO, President, and Director
Allos Therapeutics (ALTH)
Westminster, Colo.
Industry Sector
Health Care: Biotechnology & Drugs
Market Cap
$395.58 million
